Variant report
Variant | esv3459580 |
---|---|
Chromosome Location | chr2:56338448-56341124 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:56315975..56318654-chr2:56340489..56342924,2 | K562 | blood: | |
2 | chr2:56337806..56341873-chr2:56342839..56347033,7 | K562 | blood: | |
3 | chr2:56337806..56342628-chr2:56343291..56347033,6 | K562 | blood: | |
4 | chr2:56336331..56339032-chr2:56340759..56342871,3 | K562 | blood: | |
5 | chr2:56338244..56341178-chr2:56349675..56352414,2 | MCF-7 | breast: | |
6 | chr2:56336331..56339032-chr2:56340759..56342871,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229805 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545173958 | chr2:56338480-56338481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564749474 | chr2:56338532-56338533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6545543 | chr2:56338546-56338547 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
4 | rs572438360 | chr2:56338566-56338567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs367600497 | chr2:56338576-56338577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190432590 | chr2:56338628-56338629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs7558709 | chr2:56338660-56338661 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs13420560 | chr2:56338713-56338714 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs550462589 | chr2:56338765-56338766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563896507 | chr2:56338768-56338769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532694409 | chr2:56338811-56338812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551997717 | chr2:56338821-56338822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151013751 | chr2:56338869-56338870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140365912 | chr2:56338919-56338920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369626153 | chr2:56338922-56338923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549693650 | chr2:56338981-56338982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199790029 | chr2:56338993-56338994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534395281 | chr2:56339010-56339011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182675609 | chr2:56339043-56339044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187007747 | chr2:56339044-56339045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117668293 | chr2:56339045-56339046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556790440 | chr2:56339079-56339080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368714702 | chr2:56339101-56339102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373349562 | chr2:56339117-56339118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570321744 | chr2:56339131-56339132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77742331 | chr2:56339136-56339137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552888612 | chr2:56339144-56339145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149740258 | chr2:56339213-56339214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541150597 | chr2:56339292-56339293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555020070 | chr2:56339294-56339295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574859022 | chr2:56339330-56339331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191241822 | chr2:56339341-56339342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563933387 | chr2:56339384-56339385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115531945 | chr2:56339404-56339405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145584527 | chr2:56339428-56339429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116824635 | chr2:56339440-56339441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182615150 | chr2:56339462-56339463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141327694 | chr2:56339541-56339542 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567719627 | chr2:56339548-56339549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113962764 | chr2:56339560-56339561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530383709 | chr2:56339567-56339568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375513365 | chr2:56339628-56339629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147074554 | chr2:56339655-56339656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147681488 | chr2:56339663-56339664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371564196 | chr2:56339681-56339682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142347577 | chr2:56339697-56339698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10179694 | chr2:56339722-56339723 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs535145803 | chr2:56339734-56339735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555055031 | chr2:56339768-56339769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535186869 | chr2:56339781-56339782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56336400-56344000 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr2:56336600-56340600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr2:56337200-56340400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr2:56339400-56339600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr2:56339800-56347000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr2:56340000-56340200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr2:56340200-56340600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr2:56340400-56340800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr2:56340400-56341200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr2:56340400-56341200 | Enhancers | Fetal Kidney | kidney |
11 | chr2:56340400-56341200 | Enhancers | Fetal Stomach | stomach |
12 | chr2:56340600-56341000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr2:56340600-56341200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr2:56340600-56341400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr2:56340600-56344800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr2:56340800-56341000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr2:56340800-56341200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr2:56340800-56341400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr2:56341000-56341400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr2:56341000-56344000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |